SPY314.38-1.80 -0.57%
DIA257.24-3.48 -1.33%
IXIC10,547.75+55.25 0.53%

Oppenheimer Maintains Outperform on Seattle Genetics, Raises Price Target to $210

Oppenheimer maintains Seattle Genetics (NASDAQ:SGEN) with a Outperform and raises the price target from $200 to $210.

Benzinga · -
Oppenheimer maintains Seattle Genetics (NASDAQ: SGEN) with a Outperform and raises the price target from $200 to $210.